ABSTRACT
III. Oral Transmucosal Products for Angina Therapy ................................116 A. Organic Nitrate Products ...............................................................117 B. Organic Nitrate Tolerance .............................................................118 C. Non-Nitrate Vasodilators for Oral Transmucosal Delivery ..........119
IV. Regulatory Aspects ...............................................................................120 VI. Summary ...............................................................................................121
